← FDA Drug Approvals (Drugs@FDA)
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CADILA · Approved 2022-11-04
Drug application
- FDA Application #
ANDA215666- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
- Generic name
- BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
- Active ingredients
- BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CADILA
- Manufacturer
- Viona Pharmaceuticals Inc
- First approval
- 2022-11-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown